Ophthalmic Viscoelastic Devices (OVD) Market by Product Type (Cohesive Ophthalmic Viscoelastic, and Dispersive Ophthalmic Viscoelastic), Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplant and Vitreoretinal Surgery), and End User (Hospital, Ophthalmology Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
- ALL3237305
- 238 Pages
- June 2019
- Healthcare
Ophthalmic viscoelastic devices are used during the surgeries for several eye-related diseases such as cataract, glaucoma, corneal transplant, age related macular degeneration, and diabetic retinopathy. These ophthalmic visco-surgical devices are of utmost importance to provide proper treatment to the patients to avoid further damage to the vision or loss of vision. Ophthalmic viscoelastic devices play a crucial role in eye surgeries by protecting the cornea, maintaining the pressure inside eye, creating deep anterior spaces, and others. The benefits these offer have led to the rise in their use across the globe.
Rise in government initiatives that aim at setting up guidelines to control the increase in vision impairment across the globe are compelling the key manufacturers to introduce novel ophthalmic devices in the market. Moreover, surge in prevalence of cataract and glaucoma, increase in number of eye surgeries performed, and rise in geriatric population are other factors that contribute toward the growth of the market. In addition, surge in adoption of viscoelastic devices across the globe also boosts the growth of viscoelastic devices market. Furthermore, growth potential offered by developing economies present lucrative opportunities for the growth of the market during the forecast period. However, high cost of ophthalmic surgeries and low accessibility to eye care in low income countries hinder the growth of this market.
The ophthalmic viscoelastic devices market is segmented based on product, application, end user, and region to provide a detailed assessment of the market. Based on product, the market is divided into cohesive ophthalmic viscoelastic and dispersive ophthalmic viscoelastic. Based on application, the market is classified into cataract surgery, glaucoma surgery, corneal transplant, and vitreoretinal surgery. Based on end user, the market is divided into hospitals, ophthalmic clinics, others, cardiovascular disorders, and others. Based on region, the ophthalmic viscoelastic devices market size is analyzed across North America (U.S., Canada and Mexico), Europe (Germany, France, the UK, Italy, Spain and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa and rest of LAMEA).
KEY MARKET BENEFITS
• The study provides an in-depth analysis of the global ophthalmic viscoelastic devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
• The report presents a quantitative analysis of the market from 2018 to 2026 to enable stakeholders to capitalize on the prevailing market opportunities.
• An extensive analysis of the market based on application assists in understanding the trends in the industry.
• The key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Product Type
o Cohesive Ophthalmic Viscoelastic
o Dispersive Ophthalmic Viscoelastic
By Application
o Cataract
o Glaucoma
o Corneal Transplant
o Vitreoretinal Surgery
By End User
o Hospitals
o Ophthalmic Clinics
o Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Bausch Health Companies, Inc
• Eyekon Medical Inc.
• Bohus Biotech Ab
• Carl Zeiss Meditec AG
• Cima Technology Inc.
• Johnson & Johnson
• Novartis International AG (Alcon Inc.)
• Rumex International Corporation
• Haohai Biological Technology
• Altacor
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
• Hoya Corporation.
• St. Shine Optical Co, Ltd.
• CooperVision Inc.
• Tomey Corporation
• Haag-Strait AG
1.1. Report description
1.2. Key market segments
1.2.1. List of key players profiled in the report
1.3. Research methodology
1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. Key findings
2.2.1. Top impacting factors
2.2.2. Top investment pockets
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key Forces Shaping Ophthalmic Viscoelastic Devices Industry/Market
3.2.1. Moderate bargaining power of supplier
3.2.2. Low bargaining power of buyers
3.2.3. Low threat of substitutes
3.2.4. High intensity of rivalry
3.2.5. Low threat of new entrant
3.3. Pricing Analysis
3.3.1. Pricing Analysis of Cohesive Ophthalmic Viscoelastic, By Region, 2018 & 2026
3.4. Market evolution/Industry roadmap
3.5. Industry Pain point analysis
3.6. Case Study
3.6.1. Case Study
3.7. Market dynamics
3.7.1. Drivers
3.7.1.1. Rise in prevalence of cataract and glaucoma worldwide
3.7.1.2. Surge in government initiatives to control visual impairment
3.7.1.3. Rise in adoption of ophthalmic viscoelastic devices across the globe
3.7.1.4. Increase in number of ophthalmic surgeries
3.7.2. Restraints
3.7.2.1. High cost of ophthalmic surgeries
3.7.2.2. Dearth of advanced eye surgery devices and ophthalmic clinics
3.7.3. Opportunity
3.7.3.1. High potential of the emerging economies
3.7.4. Impact Analyses
CHAPTER 4: OPHTHALMIC VISCOELASTIC DEVICES (OVD) MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Cohesive Ophthalmic Viscoelastic
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis by country
4.3. Dispersive Ophthalmic Viscoelastic
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis by country
CHAPTER 5: OPHTHALMIC VISCOELASTIC DEVICES (OVD) MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Cataract Surgery
5.2.1. Market size and forecast, by region
5.2.2. Market analysis by country
5.3. Glaucoma Surgery
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Corneal Transplant
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
5.5. Vitreoretinal Surgery
5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country
CHAPTER 6: OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis by country
6.3. Ophthalmic Clinics
6.3.1. Market size and forecast, by region
6.3.2. Market analysis by country
6.4. Others
6.4.1. Market size and forecast, by region
6.4.2. Market analysis by country
CHAPTER 7: OPHTHALMIC VISCOELASTIC DEVICES (OVD) MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market analysis by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. market size and forecast, by product
7.2.2.1.2. U.S. market size and forecast, by application
7.2.2.1.3. U.S. market size and forecast, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada market size and forecast, by product
7.2.2.2.2. Canada market size and forecast, by application
7.2.2.2.3. Canada market size and forecast, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico market size and forecast, by product
7.2.2.3.2. Mexico market size and forecast, by application
7.2.2.3.3. Mexico market size and forecast, by end user
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market analysis by country
7.3.2.1. Germany
7.3.2.1.1. Germany market size and forecast, by product
7.3.2.1.2. Germany market size and forecast, by application
7.3.2.1.3. Germany market size and forecast, by end user
7.3.2.2. France
7.3.2.2.1. France market size and forecast, by product
7.3.2.2.2. France market size and forecast, by application
7.3.2.2.3. France market size and forecast, by end user
7.3.2.3. UK
7.3.2.3.1. UK market size and forecast, by product
7.3.2.3.2. UK market size and forecast, by application
7.3.2.3.3. UK market size and forecast, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy market size and forecast, by product
7.3.2.4.2. Italy market size and forecast, by application
7.3.2.4.3. Italy market size and forecast, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain market size and forecast, by product
7.3.2.5.2. Spain market size and forecast, by application
7.3.2.5.3. Spain market size and forecast, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe market size and forecast, by product
7.3.2.6.2. Rest of Europe market size and forecast, by application
7.3.2.6.3. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market analysis by country
7.4.2.1. Japan
7.4.2.1.1. Japan market size and forecast, by product
7.4.2.1.2. Japan market size and forecast, by application
7.4.2.1.3. Japan market size and forecast, by end user
7.4.2.2. China
7.4.2.2.1. China market size and forecast, by product
7.4.2.2.2. China market size and forecast, by application
7.4.2.2.3. China market size and forecast, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia market size and forecast, by product
7.4.2.3.2. Australia market size and forecast, by application
7.4.2.3.3. Australia market size and forecast, by end user
7.4.2.4. India
7.4.2.4.1. India market size and forecast, by product
7.4.2.4.2. India market size and forecast, by application
7.4.2.4.3. India market size and forecast, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea market size and forecast, by product
7.4.2.5.2. South Korea market size and forecast, by application
7.4.2.5.3. South Korea market size and forecast, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
7.4.2.6.2. Rest of Asia-Pacific market size and forecast, by application
7.4.2.6.3. Rest of Asia-Pacific market size and forecast, by end user
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.2.1. List of key players profiled in the report
1.3. Research methodology
1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. Key findings
2.2.1. Top impacting factors
2.2.2. Top investment pockets
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key Forces Shaping Ophthalmic Viscoelastic Devices Industry/Market
3.2.1. Moderate bargaining power of supplier
3.2.2. Low bargaining power of buyers
3.2.3. Low threat of substitutes
3.2.4. High intensity of rivalry
3.2.5. Low threat of new entrant
3.3. Pricing Analysis
3.3.1. Pricing Analysis of Cohesive Ophthalmic Viscoelastic, By Region, 2018 & 2026
3.4. Market evolution/Industry roadmap
3.5. Industry Pain point analysis
3.6. Case Study
3.6.1. Case Study
3.7. Market dynamics
3.7.1. Drivers
3.7.1.1. Rise in prevalence of cataract and glaucoma worldwide
3.7.1.2. Surge in government initiatives to control visual impairment
3.7.1.3. Rise in adoption of ophthalmic viscoelastic devices across the globe
3.7.1.4. Increase in number of ophthalmic surgeries
3.7.2. Restraints
3.7.2.1. High cost of ophthalmic surgeries
3.7.2.2. Dearth of advanced eye surgery devices and ophthalmic clinics
3.7.3. Opportunity
3.7.3.1. High potential of the emerging economies
3.7.4. Impact Analyses
CHAPTER 4: OPHTHALMIC VISCOELASTIC DEVICES (OVD) MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Cohesive Ophthalmic Viscoelastic
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis by country
4.3. Dispersive Ophthalmic Viscoelastic
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis by country
CHAPTER 5: OPHTHALMIC VISCOELASTIC DEVICES (OVD) MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Cataract Surgery
5.2.1. Market size and forecast, by region
5.2.2. Market analysis by country
5.3. Glaucoma Surgery
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Corneal Transplant
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
5.5. Vitreoretinal Surgery
5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country
CHAPTER 6: OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis by country
6.3. Ophthalmic Clinics
6.3.1. Market size and forecast, by region
6.3.2. Market analysis by country
6.4. Others
6.4.1. Market size and forecast, by region
6.4.2. Market analysis by country
CHAPTER 7: OPHTHALMIC VISCOELASTIC DEVICES (OVD) MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market analysis by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. market size and forecast, by product
7.2.2.1.2. U.S. market size and forecast, by application
7.2.2.1.3. U.S. market size and forecast, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada market size and forecast, by product
7.2.2.2.2. Canada market size and forecast, by application
7.2.2.2.3. Canada market size and forecast, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico market size and forecast, by product
7.2.2.3.2. Mexico market size and forecast, by application
7.2.2.3.3. Mexico market size and forecast, by end user
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market analysis by country
7.3.2.1. Germany
7.3.2.1.1. Germany market size and forecast, by product
7.3.2.1.2. Germany market size and forecast, by application
7.3.2.1.3. Germany market size and forecast, by end user
7.3.2.2. France
7.3.2.2.1. France market size and forecast, by product
7.3.2.2.2. France market size and forecast, by application
7.3.2.2.3. France market size and forecast, by end user
7.3.2.3. UK
7.3.2.3.1. UK market size and forecast, by product
7.3.2.3.2. UK market size and forecast, by application
7.3.2.3.3. UK market size and forecast, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy market size and forecast, by product
7.3.2.4.2. Italy market size and forecast, by application
7.3.2.4.3. Italy market size and forecast, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain market size and forecast, by product
7.3.2.5.2. Spain market size and forecast, by application
7.3.2.5.3. Spain market size and forecast, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe market size and forecast, by product
7.3.2.6.2. Rest of Europe market size and forecast, by application
7.3.2.6.3. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market analysis by country
7.4.2.1. Japan
7.4.2.1.1. Japan market size and forecast, by product
7.4.2.1.2. Japan market size and forecast, by application
7.4.2.1.3. Japan market size and forecast, by end user
7.4.2.2. China
7.4.2.2.1. China market size and forecast, by product
7.4.2.2.2. China market size and forecast, by application
7.4.2.2.3. China market size and forecast, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia market size and forecast, by product
7.4.2.3.2. Australia market size and forecast, by application
7.4.2.3.3. Australia market size and forecast, by end user
7.4.2.4. India
7.4.2.4.1. India market size and forecast, by product
7.4.2.4.2. India market size and forecast, by application
7.4.2.4.3. India market size and forecast, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea market size and forecast, by product
7.4.2.5.2. South Korea market size and forecast, by application
7.4.2.5.3. South Korea market size and forecast, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
7.4.2.6.2. Rest of Asia-Pacific market size and forecast, by application
7.4.2.6.3. Rest of Asia-Pacific market size and forecast, by end user
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market analysis by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil market size and forecast, by product
7.5.2.1.2. Brazil market size and forecast, by application
7.5.2.1.3. Brazil market size and forecast, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia market size and forecast, by product
7.5.2.2.2. Saudi Arabia market size and forecast, by application
7.5.2.2.3. Saudi Arabia market size and forecast, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa market size and forecast, by product
7.5.2.3.2. South Africa market size and forecast, by application
7.5.2.3.3. South Africa market size and forecast, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA market size and forecast, by product
7.5.2.4.2. Rest of LAMEA market size and forecast, by application
7.5.2.4.3. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. INTRODUCTION
8.1.1. MARKET PLAYER POSITIONING, 2018
8.2. Top winning strategies
8.3. Competitive dashboard
8.4. Competitive heatmap
CHAPTER 9: COMPANY PROFILES: OPHTHALMIC VISCOELASTIC DEVICES (OVD) MARKET
9.1. Altacor
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product type Portfolio
9.1.5. Business performance
9.2. Bausch Health Companies, Inc.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product type Portfolio
9.2.5. Business performance
9.3. Bohus Biotech Ab
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product Portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. Carl Zeiss Meditec Ag
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.5. Cima Technology Inc
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.6. Eyekon Medical Inc.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product Portfolio
9.6.5. Business performance
9.7. Haohai Biological Technology
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. Johnson & Johnson
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Product type portfolio
9.8.4. Business performance
9.9. Novartis International AG (Alcon Inc.)
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.10. Rumex International Corporation
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product Portfolio
9.10.5. Business performance
9.11. Other Key Player Profile
7.5.1. Key market trends and opportunities
7.5.2. Market analysis by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil market size and forecast, by product
7.5.2.1.2. Brazil market size and forecast, by application
7.5.2.1.3. Brazil market size and forecast, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia market size and forecast, by product
7.5.2.2.2. Saudi Arabia market size and forecast, by application
7.5.2.2.3. Saudi Arabia market size and forecast, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa market size and forecast, by product
7.5.2.3.2. South Africa market size and forecast, by application
7.5.2.3.3. South Africa market size and forecast, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA market size and forecast, by product
7.5.2.4.2. Rest of LAMEA market size and forecast, by application
7.5.2.4.3. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. INTRODUCTION
8.1.1. MARKET PLAYER POSITIONING, 2018
8.2. Top winning strategies
8.3. Competitive dashboard
8.4. Competitive heatmap
CHAPTER 9: COMPANY PROFILES: OPHTHALMIC VISCOELASTIC DEVICES (OVD) MARKET
9.1. Altacor
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product type Portfolio
9.1.5. Business performance
9.2. Bausch Health Companies, Inc.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product type Portfolio
9.2.5. Business performance
9.3. Bohus Biotech Ab
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product Portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. Carl Zeiss Meditec Ag
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.5. Cima Technology Inc
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.6. Eyekon Medical Inc.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product Portfolio
9.6.5. Business performance
9.7. Haohai Biological Technology
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. Johnson & Johnson
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Product type portfolio
9.8.4. Business performance
9.9. Novartis International AG (Alcon Inc.)
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.10. Rumex International Corporation
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product Portfolio
9.10.5. Business performance
9.11. Other Key Player ProfileCHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.2.1. List of key players profiled in the report
1.3. Research methodology
1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. Key findings
2.2.1. Top impacting factors
2.2.2. Top investment pockets
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key Forces Shaping Ophthalmic Viscoelastic Devices Industry/Market
3.2.1. Moderate bargaining power of supplier
3.2.2. Low bargaining power of buyers
3.2.3. Low threat of substitutes
3.2.4. High intensity of rivalry
3.2.5. Low threat of new entrant
3.3. Pricing Analysis
3.3.1. Pricing Analysis of Cohesive Ophthalmic Viscoelastic, By Region, 2018 & 2026
3.4. Market evolution/Industry roadmap
3.5. Industry Pain point analysis
3.6. Case Study
3.6.1. Case Study
3.7. Market dynamics
3.7.1. Drivers
3.7.1.1. Rise in prevalence of cataract and glaucoma worldwide
3.7.1.2. Surge in government initiatives to control visual impairment
3.7.1.3. Rise in adoption of ophthalmic viscoelastic devices across the globe
3.7.1.4. Increase in number of ophthalmic surgeries
3.7.2. Restraints
3.7.2.1. High cost of ophthalmic surgeries
3.7.2.2. Dearth of advanced eye surgery devices and ophthalmic clinics
3.7.3. Opportunity
3.7.3.1. High potential of the emerging economies
3.7.4. Impact Analyses
CHAPTER 4: OPHTHALMIC VISCOELASTIC DEVICES (OVD) MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Cohesive Ophthalmic Viscoelastic
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis by country
4.3. Dispersive Ophthalmic Viscoelastic
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis by country
CHAPTER 5: OPHTHALMIC VISCOELASTIC DEVICES (OVD) MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Cataract Surgery
5.2.1. Market size and forecast, by region
5.2.2. Market analysis by country
5.3. Glaucoma Surgery
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Corneal Transplant
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
5.5. Vitreoretinal Surgery
5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country
CHAPTER 6: OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis by country
6.3. Ophthalmic Clinics
6.3.1. Market size and forecast, by region
6.3.2. Market analysis by country
6.4. Others
6.4.1. Market size and forecast, by region
6.4.2. Market analysis by country
CHAPTER 7: OPHTHALMIC VISCOELASTIC DEVICES (OVD) MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market analysis by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. market size and forecast, by product
7.2.2.1.2. U.S. market size and forecast, by application
7.2.2.1.3. U.S. market size and forecast, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada market size and forecast, by product
7.2.2.2.2. Canada market size and forecast, by application
7.2.2.2.3. Canada market size and forecast, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico market size and forecast, by product
7.2.2.3.2. Mexico market size and forecast, by application
7.2.2.3.3. Mexico market size and forecast, by end user
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market analysis by country
7.3.2.1. Germany
7.3.2.1.1. Germany market size and forecast, by product
7.3.2.1.2. Germany market size and forecast, by application
7.3.2.1.3. Germany market size and forecast, by end user
7.3.2.2. France
7.3.2.2.1. France market size and forecast, by product
7.3.2.2.2. France market size and forecast, by application
7.3.2.2.3. France market size and forecast, by end user
7.3.2.3. UK
7.3.2.3.1. UK market size and forecast, by product
7.3.2.3.2. UK market size and forecast, by application
7.3.2.3.3. UK market size and forecast, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy market size and forecast, by product
7.3.2.4.2. Italy market size and forecast, by application
7.3.2.4.3. Italy market size and forecast, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain market size and forecast, by product
7.3.2.5.2. Spain market size and forecast, by application
7.3.2.5.3. Spain market size and forecast, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe market size and forecast, by product
7.3.2.6.2. Rest of Europe market size and forecast, by application
7.3.2.6.3. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market analysis by country
7.4.2.1. Japan
7.4.2.1.1. Japan market size and forecast, by product
7.4.2.1.2. Japan market size and forecast, by application
7.4.2.1.3. Japan market size and forecast, by end user
7.4.2.2. China
7.4.2.2.1. China market size and forecast, by product
7.4.2.2.2. China market size and forecast, by application
7.4.2.2.3. China market size and forecast, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia market size and forecast, by product
7.4.2.3.2. Australia market size and forecast, by application
7.4.2.3.3. Australia market size and forecast, by end user
7.4.2.4. India
7.4.2.4.1. India market size and forecast, by product
7.4.2.4.2. India market size and forecast, by application
7.4.2.4.3. India market size and forecast, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea market size and forecast, by product
7.4.2.5.2. South Korea market size and forecast, by application
7.4.2.5.3. South Korea market size and forecast, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
7.4.2.6.2. Rest of Asia-Pacific market size and forecast, by application
7.4.2.6.3. Rest of Asia-Pacific market size and forecast, by end user
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market analysis by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil market size and forecast, by product
7.5.2.1.2. Brazil market size and forecast, by application
7.5.2.1.3. Brazil market size and forecast, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia market size and forecast, by product
7.5.2.2.2. Saudi Arabia market size and forecast, by application
7.5.2.2.3. Saudi Arabia market size and forecast, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa market size and forecast, by product
7.5.2.3.2. South Africa market size and forecast, by application
7.5.2.3.3. South Africa market size and forecast, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA market size and forecast, by product
7.5.2.4.2. Rest of LAMEA market size and forecast, by application
7.5.2.4.3. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. INTRODUCTION
8.1.1. MARKET PLAYER POSITIONING, 2018
8.2. Top winning strategies
8.3. Competitive dashboard
8.4. Competitive heatmap
CHAPTER 9: COMPANY PROFILES: OPHTHALMIC VISCOELASTIC DEVICES (OVD) MARKET
9.1. Altacor
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product type Portfolio
9.1.5. Business performance
9.2. Bausch Health Companies, Inc.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product type Portfolio
9.2.5. Business performance
9.3. Bohus Biotech Ab
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product Portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. Carl Zeiss Meditec Ag
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.5. Cima Technology Inc
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.6. Eyekon Medical Inc.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product Portfolio
9.6.5. Business performance
9.7. Haohai Biological Technology
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. Johnson & Johnson
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Product type portfolio
9.8.4. Business performance
9.9. Novartis International AG (Alcon Inc.)
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.10. Rumex International Corporation
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product Portfolio
9.10.5. Business performance
9.11. Other Key Player Profile
TABLE 01. GLOBAL OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY PRODUCT, 2018-2026 ($MILLION)
TABLE 02. COHESIVE OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03. DISPERSIVE OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. GLOBAL OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 05. OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE FOR CATARACT SURGERY, BY REGION 2018–2026($MILLION)
TABLE 06. OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE FOR GLAUCOMA SURGERY, BY REGION 2018–2026 ($MILLION)
TABLE 07. OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE FOR CORNEAL TRANSPLANT, BY REGION 2018–2026 ($MILLION)
TABLE 08. OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE FOR VITRORETINAL SURGERY, BY REGION 2018–2026 ($MILLION)
TABLE 09. GLOBAL OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 10. HOSPITALS OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY REGION 2018–2026 ($MILLION)
TABLE 11. OPHTHALMIC CLINICS OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY REGION 2018–2026 ($MILLION)
TABLE 12. OTHERS OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY REGION 2018–2026 ($MILLION)
TABLE 13. OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY REGION, 2018-2026 ($MILLION)
TABLE 14. NORTH AMERICA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY COUNTRY 2019–2026 ($MILLION)
TABLE 15. U.S. OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 16. U.S. OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 17. U.S. OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 18. CANADA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 19. CANADA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 20. CANADA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 21. MEXICO OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 22. MEXICO OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 23. MEXICO OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 24. NORTH AMERICA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026($MILLION)
TABLE 25. NORTH AMERICA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026($MILLION)
TABLE 26. NORTH AMERICA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026($MILLION)
TABLE 27. EUROPE OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY COUNTRY 2019–2026 ($MILLION)
TABLE 28. GERMANY OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 29. GERMANY OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 30. GERMANY OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 31. FRANCE OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 32. FRANCE OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 33. FRANCE OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 34. UK OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 35. UK OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 36. UK OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 37. ITALY OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 38. ITALY OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 39. ITALY OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 40. SPAIN OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 41. SPAIN OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 42. SPAIN OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 43. REST OF EUROPE OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 44. REST OF EUROPE OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 45. REST OF EUROPE OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 46. EUROPE OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026($MILLION)
TABLE 47. EUROPE OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026($MILLION)
TABLE 48. EUROPE OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026($MILLION)
TABLE 49. ASIA-PACIFIC OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY COUNTRY 2019–2026 ($MILLION)
TABLE 50. JAPAN OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 51. JAPAN OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 52. JAPAN OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 53. CHINA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 54. CHINA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 55. CHINA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 56. AUSTRALIA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 57. AUSTRALIA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 58. AUSTRALIA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 59. INDIA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 60. INDIA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 61. INDIA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 62. SOUTH KOREA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 63. SOUTH KOREA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 64. SPAIN OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 68. ASIA-PACIFIC OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026($MILLION)
TABLE 69. ASIA-PACIFIC OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026($MILLION)
TABLE 70. ASIA-PACIFIC OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026($MILLION)
TABLE 71. LAMEA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY COUNTRY 2019–2026 ($MILLION)
TABLE 72. BRAZIL OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 73. BRAZIL OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 74. BRAZIL OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 75. SAUDI ARABIA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 76. SAUDI ARABIA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 77. SAUDI ARABIA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 78. SOUTH AFRICA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 79. SOUTH AFRICA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 80. SOUTH AFRICA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 81. REST OF LAMEA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026 ($MILLION)
TABLE 82. REST OF LAMEA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)
TABLE 83. REST OF LAMEA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026 ($MILLION)
TABLE 84. LAMEA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY PRODUCT 2019–2026($MILLION)
TABLE 85. LAMEA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY APPLICATION 2019–2026($MILLION)
TABLE 86. LAMEA OPHTHALMIC VISCOELASTIC DEVICES MARKET REVENUE, BY END USER 2019–2026($MILLION)
TABLE 87. ALTACOR: COMPANY SNAPSHOT
TABLE 88. ALTACOR: OPERATING SEGMENTS
TABLE 89. ALTACOR: PRODUCT TYPE PORTFOLIO
TABLE 90. BAUSCH: COMPANY SNAPSHOT
TABLE 91. BAUSCH: OPERATING SEGMENTS
TABLE 92. BAUSCH: PRODUCT TYPE PORTFOLIO
TABLE 93. BOHUS: COMPANY SNAPSHOT
TABLE 94. BOHUS: OPERATING SEGMENTS
TABLE 95. BOHUS: PRODUCT PORTFOLIO
TABLE 96. ZEISS: COMPANY SNAPSHOT
TABLE 97. ZEISS: OPERATING SEGMENTS
TABLE 98. ZEISS: PRODUCT PORTFOLIO
TABLE 99. CIMA TECHNOLOGY: COMPANY SNAPSHOT
TABLE 100. CIMA TECHNOLOGY: OPERATING SEGMENTS
TABLE 101. CIMA TECHNOLOGY: PRODUCT PORTFOLIO
TABLE 102. EYEKON: COMPANY SNAPSHOT
TABLE 103. EYEKON: OPERATING SEGMENTS
TABLE 104. EYEKON: PRODUCT PORTFOLIO
TABLE 105. HAOHAI: COMPANY SNAPSHOT
TABLE 106. HAOHAI: OPERATING SEGMENTS
TABLE 107. HAOHAI: PRODUCT TYPE PORTFOLIO
TABLE 108. J&J: COMPANY SNAPSHOT
TABLE 109. J&J: PRODUCT TYPE PORTFOLIO
TABLE 110. NOVARTIS: COMPANY SNAPSHOT
TABLE 111. NOVARTIS: OPERATING SEGMENTS
TABLE 112. NOVARTIS: PRODUCT PORTFOLIO
TABLE 113. RUMEX: COMPANY SNAPSHOT
TABLE 114. RUMEX: OPERATING SEGMENTS
TABLE 115. RUMEX: PRODUCT PORTFOLIO
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
